Frontlight ResearchEarly access
Trial site
DOM Centro de Reumatología
- 7running trials
- 4closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Lupus (SLE)3 trials
- Sjögren's disease3 trials
- Atopic dermatitis (eczema)1 trial
- Crohn's disease1 trial
- Duchenne muscular dystrophy1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- IgA nephropathy1 trial
- Phase
- Phase 39 trials
- Phase 21 trial
- Phase 41 trial
- Status
- Active, not recruiting4 trials
- Completed3 trials
- Recruiting3 trials
- Terminated1 trial
- Lead sponsor
- Amgen4 trials
- Eli Lilly and Company3 trials
- Hoffmann-La Roche2 trials
- Biogen1 trial
- Sarepta Therapeutics, Inc.1 trial
Running trials
Recruiting
Recruiting
Recruiting
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Fatty liver disease (MASLD/MASH)1 recruiting
- IgA nephropathy1 recruiting
- Sjögren's disease1 recruiting
Closed trials
Completed
Completed
Terminated
Study of Daxdilimab (HZN-7734) in Participants With Active Proliferative Lupus Nephritis (LN)
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026